Clinical Trial Update: Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating EP-104IAR for knee osteoarthritis has completed. Results were posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• EP-104IAR

Snippet

Sponsor: Eupraxia Pharmaceuticals Inc. | Conditions: Osteoarthritis, Knee | Phase 2 | Status: COMPLETED | Results posted: 2024-06-25